Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business ...

Thermo Fisher Scientific confirmed that it agreed to purchase Solventum's purification and fitration unit for $4.1 billion in ...

Thermo Fisher Scientific is nearing a deal for Solventum’s purification and filtration business, according to people familiar ...

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...

Thermo Fisher Scientific is buying Solventum’s purification and filtration business unit in a cash deal worth around $4.1bn.

Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics ...

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo ...

Thermo Fisher (TMO) is close to a deal for Solventum’s (SOLV) purification and filtration business, The Wall Street Journal’s Lauren Thomas ...

A transaction is expected to value the filtration business between $3.5 billion and $4 billion, the people added.